TY - JOUR
T1 - Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS)
T2 - A prospective, case-control study
AU - Kotloff, Karen L.
AU - Nataro, James P.
AU - Blackwelder, William C.
AU - Nasrin, Dilruba
AU - Farag, Tamer H.
AU - Panchalingam, Sandra
AU - Wu, Yukun
AU - Sow, Samba O.
AU - Sur, Dipika
AU - Breiman, Robert F.
AU - Faruque, Abu S.G.
AU - Zaidi, Anita K.M.
AU - Saha, Debasish
AU - Alonso, Pedro L.
AU - Tamboura, Boubou
AU - Sanogo, Doh
AU - Onwuchekwa, Uma
AU - Manna, Byomkesh
AU - Ramamurthy, Thandavarayan
AU - Kanungo, Suman
AU - Ochieng, John B.
AU - Omore, Richard
AU - Oundo, Joseph O.
AU - Hossain, Anowar
AU - Das, Sumon K.
AU - Ahmed, Shahnawaz
AU - Qureshi, Shahida
AU - Quadri, Farheen
AU - Adegbola, Richard A.
AU - Antonio, Martin
AU - Hossain, M. Jahangir
AU - Akinsola, Adebayo
AU - Mandomando, Inacio
AU - Nhampossa, Tacilta
AU - Acácio, Sozinho
AU - Biswas, Kousick
AU - O'Reilly, Ciara E.
AU - Mintz, Eric D.
AU - Berkeley, Lynette Y.
AU - Muhsen, Khitam
AU - Sommerfelt, Halvor
AU - Robins-Browne, Roy M.
AU - Levine, Myron M.
N1 - Funding Information:
MML conceived the project and acquired the grant funds. MML, KLK, and JPN designed the protocol. WCB did the statistical analysis with YW, DN, HS, THF, and KM. KLK, JPN, DN, THF, SP, LB, SOS, DSu, RFB, ASGF, AKMZ, RAA, DSah, PLA, EDM, and CEOR planned and supervised the study. DSan, SK, RO, SKD, SA, FQ, AA, TN, and SA coordinated clinical data collection; BT, TR, JBO, JOO, AH, SQ, MA, IM, and RMR-B did the laboratory assays; and UO, BM, MJH, and KB participated in data management. KLK, WCB, DN, THF, YW, KM, JPN, and MML had full access to all the data in the study and did data analysis; KLK wrote the report with input from all authors and had final responsibility for the decision to submit for publication. All authors reviewed the draft and approved the decision to submit for publication.
PY - 2013
Y1 - 2013
N2 - Summary Background Diarrhoeal diseases cause illness and death among children younger than 5 years in low-income countries. We designed the Global Enteric Multicenter Study (GEMS) to identify the aetiology and population-based burden of paediatric diarrhoeal disease in sub-Saharan Africa and south Asia. Methods The GEMS is a 3-year, prospective, age-stratified, matched case-control study of moderate-to-severe diarrhoea in children aged 0-59 months residing in censused populations at four sites in Africa and three in Asia. We recruited children with moderate-to-severe diarrhoea seeking care at health centres along with one to three randomly selected matched community control children without diarrhoea. From patients with moderate-to-severe diarrhoea and controls, we obtained clinical and epidemiological data, anthropometric measurements, and a faecal sample to identify enteropathogens at enrolment; one follow-up home visit was made about 60 days later to ascertain vital status, clinical outcome, and interval growth. Findings We enrolled 9439 children with moderate-to-severe diarrhoea and 13â€̂129 control children without diarrhoea. By analysing adjusted population attributable fractions, most attributable cases of moderate-to-severe diarrhoea were due to four pathogens: rotavirus, Cryptosporidium, enterotoxigenic Escherichia coli producing heat-stable toxin (ST-ETEC; with or without co-expression of heat-labile enterotoxin), and Shigella. Other pathogens were important in selected sites (eg, Aeromonas, Vibrio cholerae O1, Campylobacter jejuni). Odds of dying during follow-up were 8·5-fold higher in patients with moderate-to-severe diarrhoea than in controls (odd ratio 8·5, 95% CI 5·8-12·5, p<0·0001); most deaths (167 [87·9%]) occurred during the first 2 years of life. Pathogens associated with increased risk of case death were ST-ETEC (hazard ratio [HR] 1·9; 0·99-3·5) and typical enteropathogenic E coli (HR 2·6; 1·6-4·1) in infants aged 0-11 months, and Cryptosporidium (HR 2·3; 1·3-4·3) in toddlers aged 12-23 months. Interpretation Interventions targeting five pathogens (rotavirus, Shigella, ST-ETEC, Cryptosporidium, typical enteropathogenic E coli) can substantially reduce the burden of moderate-to-severe diarrhoea. New methods and accelerated implementation of existing interventions (rotavirus vaccine and zinc) are needed to prevent disease and improve outcomes. Funding The Bill & Melinda Gates Foundation.
AB - Summary Background Diarrhoeal diseases cause illness and death among children younger than 5 years in low-income countries. We designed the Global Enteric Multicenter Study (GEMS) to identify the aetiology and population-based burden of paediatric diarrhoeal disease in sub-Saharan Africa and south Asia. Methods The GEMS is a 3-year, prospective, age-stratified, matched case-control study of moderate-to-severe diarrhoea in children aged 0-59 months residing in censused populations at four sites in Africa and three in Asia. We recruited children with moderate-to-severe diarrhoea seeking care at health centres along with one to three randomly selected matched community control children without diarrhoea. From patients with moderate-to-severe diarrhoea and controls, we obtained clinical and epidemiological data, anthropometric measurements, and a faecal sample to identify enteropathogens at enrolment; one follow-up home visit was made about 60 days later to ascertain vital status, clinical outcome, and interval growth. Findings We enrolled 9439 children with moderate-to-severe diarrhoea and 13â€̂129 control children without diarrhoea. By analysing adjusted population attributable fractions, most attributable cases of moderate-to-severe diarrhoea were due to four pathogens: rotavirus, Cryptosporidium, enterotoxigenic Escherichia coli producing heat-stable toxin (ST-ETEC; with or without co-expression of heat-labile enterotoxin), and Shigella. Other pathogens were important in selected sites (eg, Aeromonas, Vibrio cholerae O1, Campylobacter jejuni). Odds of dying during follow-up were 8·5-fold higher in patients with moderate-to-severe diarrhoea than in controls (odd ratio 8·5, 95% CI 5·8-12·5, p<0·0001); most deaths (167 [87·9%]) occurred during the first 2 years of life. Pathogens associated with increased risk of case death were ST-ETEC (hazard ratio [HR] 1·9; 0·99-3·5) and typical enteropathogenic E coli (HR 2·6; 1·6-4·1) in infants aged 0-11 months, and Cryptosporidium (HR 2·3; 1·3-4·3) in toddlers aged 12-23 months. Interpretation Interventions targeting five pathogens (rotavirus, Shigella, ST-ETEC, Cryptosporidium, typical enteropathogenic E coli) can substantially reduce the burden of moderate-to-severe diarrhoea. New methods and accelerated implementation of existing interventions (rotavirus vaccine and zinc) are needed to prevent disease and improve outcomes. Funding The Bill & Melinda Gates Foundation.
UR - http://www.scopus.com/inward/record.url?scp=84880508179&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(13)60844-2
DO - 10.1016/S0140-6736(13)60844-2
M3 - Article
C2 - 23680352
AN - SCOPUS:84880508179
SN - 0140-6736
VL - 382
SP - 209
EP - 222
JO - The Lancet
JF - The Lancet
IS - 9888
ER -